A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found ...
Concurrently, a preprint from the industry-backed Vital Transformation found a 50% drop in company investments into ...
Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Hosted on MSN1d
Medicare caps seniors’ drug costs at $2,000Starting in January, seniors enrolled in Medicare will see a significant reduction in their out-of-pocket costs for ...
People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...
Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback